» Articles » PMID: 38858390

Aberrant ER-mitochondria Communication is a Common Pathomechanism in Mitochondrial Disease

Overview
Journal Cell Death Dis
Date 2024 Jun 10
PMID 38858390
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic mutations causing primary mitochondrial disease (i.e those compromising oxidative phosphorylation [OxPhos]) resulting in reduced bioenergetic output display great variability in their clinical features, but the reason for this is unknown. We hypothesized that disruption of the communication between endoplasmic reticulum (ER) and mitochondria at mitochondria-associated ER membranes (MAM) might play a role in this variability. To test this, we assayed MAM function and ER-mitochondrial communication in OxPhos-deficient cells, including cybrids from patients with selected pathogenic mtDNA mutations. Our results show that each of the various mutations studied indeed altered MAM functions, but notably, each disorder presented with a different MAM "signature". We also found that mitochondrial membrane potential is a key driver of ER-mitochondrial connectivity. Moreover, our findings demonstrate that disruption in ER-mitochondrial communication has consequences for cell survivability that go well beyond that of reduced ATP output. The findings of a "MAM-OxPhos" axis, the role of mitochondrial membrane potential in controlling this process, and the contribution of MAM dysfunction to cell death, reveal a new relationship between mitochondria and the rest of the cell, as well as providing new insights into the diagnosis and treatment of these devastating disorders.

Citing Articles

Recent development of mitochondrial metabolism and dysfunction in osteoarthritis.

Guo P, Alhaskawi A, Adel Abdo Moqbel S, Pan Z Front Pharmacol. 2025; 16:1538662.

PMID: 40017603 PMC: 11865096. DOI: 10.3389/fphar.2025.1538662.


Modulation of Mitochondria-Endoplasmic Reticulum Contacts (MERCs) by Small Molecules as a New Strategy for Restoring Lipid Metabolism in an Amyotrophic Lateral Sclerosis Model.

Etxebeste-Mitxeltorena M, Flores-Romero H, Ramos-Inza S, Masia E, Nenchova M, Montesinos J J Med Chem. 2025; 68(2):1179-1194.

PMID: 39778888 PMC: 11770630. DOI: 10.1021/acs.jmedchem.4c01368.


Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell.

Paraskevaidis I, Kourek C, Farmakis D, Tsougos E Biomolecules. 2025; 14(12.

PMID: 39766241 PMC: 11673776. DOI: 10.3390/biom14121534.


The AICD interactome: implications in neurodevelopment and neurodegeneration.

Ng L, Chow J, Lau K Biochem Soc Trans. 2024; 52(6):2539-2556.

PMID: 39670668 PMC: 11668293. DOI: 10.1042/BST20241510.

References
1.
Martins de Brito O, Scorrano L . Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature. 2008; 456(7222):605-10. DOI: 10.1038/nature07534. View

2.
Cardenas C, Lovy A, Silva-Pavez E, Urra F, Mizzoni C, Ahumada-Castro U . Cancer cells with defective oxidative phosphorylation require endoplasmic reticulum-to-mitochondria Ca transfer for survival. Sci Signal. 2020; 13(640). PMC: 9387586. DOI: 10.1126/scisignal.aay1212. View

3.
Gilkerson R, de Vries R, Lebot P, Wikstrom J, Torgyekes E, Shirihai O . Mitochondrial autophagy in cells with mtDNA mutations results from synergistic loss of transmembrane potential and mTORC1 inhibition. Hum Mol Genet. 2011; 21(5):978-90. PMC: 3277306. DOI: 10.1093/hmg/ddr529. View

4.
Russell O, Gorman G, Lightowlers R, Turnbull D . Mitochondrial Diseases: Hope for the Future. Cell. 2020; 181(1):168-188. DOI: 10.1016/j.cell.2020.02.051. View

5.
Mirabella M, Di Giovanni S, Silvestri G, Tonali P, Servidei S . Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain. 1999; 123 ( Pt 1):93-104. DOI: 10.1093/brain/123.1.93. View